Page last updated: 2024-09-05

erlotinib hydrochloride and B16 Melanoma

erlotinib hydrochloride has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hoeller, C; Kunstfeld, R; Loewe, R; Paulitschke, V; Pehamberger, H; Pilarski, P; Schicher, N; Swoboda, A	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and B16 Melanoma

Article	Year
Erlotinib and bevacizumab have synergistic activity against melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoblotting; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, SCID; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays	2009

Article

Year

Erlotinib and bevacizumab have synergistic activity against melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoblotting; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, SCID; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays

2009